The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADAMAS PHARMACEUTICALS INC COM 00548A106 2,709 657,467 SH   SOLE   657,467 0 0
AFFIMED NV COM N01045108 1,212 357,666 SH   SOLE   357,666 0 0
AMRYT PHARMA LTD - SPNR ADR SPONSORED ADS 03217L106 9,458 765,236 SH   SOLE   765,236 0 0
APOLLO ENDOSURGERY INC COM 03767D108 2,409 1,425,435 SH   SOLE   1,425,435 0 0
ANTARES PHARMA INC COM 036642106 3,255 1,205,501 SH   SOLE   1,205,501 0 0
CATALYST BIOSCIENCES INC COM NEW 14888D208 6,069 1,411,412 SH   SOLE   1,411,412 0 0
CHIASMA INC COM 16706W102 1,505 350,000 SH   SOLE   350,000 0 0
CUMBERLAND PHARMACEUTICALS COM 230770109 1,892 589,497 SH   SOLE   589,497 0 0
CTI BIOPHARMA CORP COM 12648L601 8,102 3,768,597 SH   SOLE   3,768,597 0 0
DIAMEDICA THERAPEUTICS INC COM NEW 25253X207 4,861 1,146,470 SH   SOLE   1,146,470 0 0
INTERPACE BIOSCIENCES INC COM 46062X303 880 284,730 SH   SOLE   284,730 0 0
IVERIC BIO INC COM 46583P102 13,323 2,362,240 SH   SOLE   2,362,240 0 0
LIGAND PHARMACEUTICALS COM NEW 53220K504 30,645 321,500 SH   SOLE   321,500 0 0
NEOS THERAPEUTICS INC COM 64052L106 2,325 4,384,199 SH   SOLE   4,384,199 0 0
PROGENITY INC COM 74319F107 614 68,062 SH   SOLE   68,062 0 0
STRONGBRIDGE BIOPHARMA PLC SHS USD G85347105 4,042 1,924,956 SH   SOLE   1,924,956 0 0
XOMA CORP COM NEW 98419J206 2,830 150,213 SH   SOLE   150,213 0 0